Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to TNFRSF11A (ENSG00000267341)
- Target
- ENSG00000267341
- Molecular classification
- Long non-coding RNA (lncRNA)
01
Overview
The "novel transcript, antisense to TNFRSF11A" (ENSG00000267341) is a long non-coding RNA gene annotated on the opposite strand of the TNFRSF11A locus. It does not code for a protein and its functional properties and relevance remain uncharacterized in the current literature. Most available information does not attribute known biological activity, disease involvement, or clinical utility to this transcript. It is important to note that TNFRSF11A is a protein-coding gene encoding RANK, a receptor involved in bone remodeling and immune regulation, but the "novel transcript, antisense to TNFRSF11A" is a lncRNA and is not RANK. This transcript should not be confused with TNFRSF11A or RANK receptor, which is a well-established therapeutic target.
02
Mechanism of action
None known. It is not a pharmacologically targeted molecule, so there are no mechanisms of drug action described.
03
Biological functions
Unknown. No well-established biological functions are attributed to this specific transcript. Long non-coding RNAs in general can have regulatory roles, but function for this transcript is uncharacterized.
04
Disease associations
Unknown. No direct evidence links this transcript to disease processes; the parent sense gene TNFRSF11A is involved in bone remodeling disorders (Paget’s disease, osteopetrosis), but this antisense RNA’s disease relevance is not documented.
Beyond the preview
Go deeper on Novel transcript, antisense to TNFRSF11A (ENSG00000267341).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel transcript, antisense to TNFRSF11A (ENSG00000267341).